Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
remetinostat (SHP-141)
i
Other names:
SHP-141, SHAPE, SHP-141C
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Medivir
Drug class:
HDAC inhibitor
Related drugs:
‹
chidamide (23)
vorinostat (19)
panobinostat (15)
romidepsin (9)
entinostat (9)
CUDC-907 (8)
OKI-179 (4)
SB939 (4)
belinostat (2)
CG-781 (2)
MGCD0103 (2)
REC-2282 (1)
4SC-202 (1)
JNJ 26481585 (1)
CUDC-101 (0)
givinostat (0)
resminostat (0)
RG2833 (0)
sulforafan alfadex (0)
CKD-581 (0)
histone deacetylase inhibitors/hypomethylating agents (0)
CG-745 (0)
kt-3000 series (0)
kt-3283 (0)
VRx-3996 (0)
MTX110 (0)
OBP-801 (0)
EDO-S101 (0)
VTR-297 (0)
CXD101 (0)
chidamide (23)
vorinostat (19)
panobinostat (15)
romidepsin (9)
entinostat (9)
CUDC-907 (8)
OKI-179 (4)
SB939 (4)
belinostat (2)
CG-781 (2)
MGCD0103 (2)
REC-2282 (1)
4SC-202 (1)
JNJ 26481585 (1)
CUDC-101 (0)
givinostat (0)
resminostat (0)
RG2833 (0)
sulforafan alfadex (0)
CKD-581 (0)
histone deacetylase inhibitors/hypomethylating agents (0)
CG-745 (0)
kt-3000 series (0)
kt-3283 (0)
VRx-3996 (0)
MTX110 (0)
OBP-801 (0)
EDO-S101 (0)
VTR-297 (0)
CXD101 (0)
›
Associations
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer (NCT03180528)
Phase 2
Kavita Sarin
Kavita Sarin
Completed
Phase 2
Kavita Sarin
Completed
Last update posted :
06/08/2021
Initiation :
07/07/2018
Primary completion :
07/07/2020
Completion :
12/31/2020
STAT3 • GLI1
|
remetinostat (SHP-141)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login